GlassScriptPhysician profile
Vicki Reynolds
NPI 1083632848
$1,425.48
in general payments reported to CMS, 2019-2025
15 companies · $375 in 2025
The $375 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $278 · 2022: $286 · 2023: $104 · 2024: $383 · 2025: $375.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $862.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $862.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $556.15 | 2022-2025 | Impella |
| Abbott Laboratories | $371.32 | 2021-2025 | Thoratec Heartmate 3 Lvas Implant Kit, Cardiomems |
| La Jolla Pharmaceutical Company | $141.33 | 2021-2024 | Giapreza |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $110.78 | 2022-2025 | Lifevest |
| Merck Sharp & Dohme LLC | $43.64 | 2022-2024 | Verquvo |
| Preventice Services, LLC | $30.13 | 2021 | |
| Livanova USA, INC. | $27.36 | 2022 | |
| Kestra Medical Technology Services, INC. | $22.97 | 2023 | Assure Wcd |
| Bridgebio Pharma, INC. | $20.62 | 2025 | Attruby |
| Lexicon Pharmaceuticals, INC. | $20.28 | 2023 | Inpefa |
| Watermark Medical, INC. | $18.02 | 2025 | |
| Edwards Lifesciences Corporation | $17.58 | 2024 | |
| Astrazeneca Pharmaceuticals LP | $16.35 | 2023 | Brilinta |
| Hologic Sales and Service, LLC | $14.87 | 2024 | Myosure Tissue Removal Device |
| Paladin Technology Solutions | $14.08 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vicki Reynolds listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.